Contact Us

15F, 27, Teheran-ro 2-gil
Gangnam-gu, Seoul 06241
Republic of Korea
Jussarang Lee

More »

Lunit is an AI software company devoted to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit has been named by CB Insights as one of “AI 100” startups transforming healthcare industry and "Digital Health 150" companies. Lunit has been chosen by World Economic Forum as one of "Technology Pioneers" that shape the future.

Through AI solutions for diagnostic and therapeutic biomarkers, we aim to solve the most critical issues in cancer care today: reduce medical cost and prolong survival.

Subscribe to our YouTube Channel.

News Releases
Nov 22, 2021

Seoul, Korea -- Lunit, a leading medical AI provider, announced that there will be 13 abstracts presented at this year’s RSNA, demonstrating its AI solutions for radiology through internally...

Nov 18, 2021

Lunit announces FDA 510(k) clearance for Lunit INSIGHT MMG, now available for clinical use in US hospitals and medical institutions AI can detect breast cancer at an earlier stage; accuracy proven...

Nov 15, 2021

First FDA 510(k) clearance from its AI software product lineup for radiology, specialized in triaging emergent cases found in chest x-ray Company to accelerate business in the US market,...

Nov 4, 2021

With its most mature product--Lunit INSIGHT CXR and Lunit INSIGHT MMG--now clinically used in more than 30 countries, the company expands its AI product line for radiology Lunit INSIGHT to DBT and...

Nov 27, 2020

Seoul, Korea-- Lunit, a leading medical AI software company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions for chest x-ray and...

More »